Sonic Healthcare – Buy
SHL:ASX is under Algo Engine buy conditions and is a current holding in our ASX model portfolio.
FY22 revenue is likely to be around $7.6bn on EBITDA of $1.7bn. EPS growth will moderate to 5 – 10%, which will continue to support a forward yield of 3.5%.
The short-term momentum indicators are now pointing higher, as buying increases above the $30 support level.